id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S17249 R72197 |
Kaufman - Beta-blockers, 2024 | Low birth weight (< 2500g) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No | 0.88 [0.08;9.23] C | 3/44 1/13 | 4 | 44 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13934 R55577 |
Hashimoto - Beta-blockers, 2021 | Low birth weight (ICD-10 P07.0, P07.1) | 1st trimester | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes | 0.87 [0.11;6.67] | 1/31 44/735 | 45 | 31 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S14054 R55587 |
Pellegrino - Timolol, 2018 | Low Birth Weight (< 2500g) | throughout pregnancy | prospective cohort | unexposed, disease free | Adjustment: No | 1.06 [0.23;4.98] C | 2/22 15/174 | 17 | 22 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13909 R55574 |
Ho - Beta-blockers, 2009 | Low birth weight (< 2500 g) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, disease free | Adjustment: Yes | 1.48 [0.86;2.56] | 17/189 120/1,952 | 137 | 189 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 4 studies | 1.36 [0.83;2.21] | 203 | 286 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded